During the acute phase of inflammation in AD, OX40/OX40 L signaling promotes differentiation of Th2 cells, which express more OX40 and secrete cytokines that will promote rupture of the epidermal barrier, activating antigen-presenting cells that will subsequently express OX40 L. Here, TNFRSF4 is linked to Alzheimer disease.